MessageFrom: Buehler, Gary J
Sent: Wednesday, August 06, 2003 11:06 AM
To: Dockets, FDA
Subject: FW: Generic Ribavirin


-----Original Message-----
From: Dan Kelsey [mailto:dkelsey@cableone.net] 
Sent: Wednesday, August 06, 2003 11:23 AM
To: buehler@cder.fda.gov
Subject: Generic Ribavirin


Dear Director Buehler and Dockets Management staff,

I am writing to strongly urge FDA to immediately approve generic ribavirin capsules for use in the treatment of hepatitis C and to oppose the recently submitted "Citizen Petition" by the brand manufacture of this drug simply designed to delay that approval. The petition is yet another tactic by brand drug makers to misuse the FDA in a desperate effort to deny people with hepatitis C legal and timely access to competitive, safe, effective, lower cost equivalent treatments. 

Please approve generic ribavirin applications as soon as possible! 

Daniel Kelsey
Work Incentives Specialist
New Horizons Independent Living Center
8085 E Manley, Suite 1
Prescott Valley, AZ  86314
 Ph  (928) 772-1266
Fax  (928) 772-3808
Transportation/TTY (928) 775-8870